Intraventricular streptokinase after intraventricular hemorrhage in newborn infants

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2007, Pages

  Whitelaw, Andrew ^a   Odd, D E ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b NONE

Author keywords

*Cerebral ventricles; *Therapeutic use ; Cerebral hemorrhage complications; *drug therapy ; Fibrinolytic agents administration dosage; Hydrocephalus etiology; prevention control ; Infant, newborn

Indexed keywords

STREPTOKINASE;

BLEEDING; BRAIN HEMORRHAGE; BRAIN VENTRICLE DILATATION; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEALTH HAZARD; HUMAN; HYDROCEPHALUS; MENINGITIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SHUNTING; SURVIVAL; TREATMENT DURATION;

EID: 44949141526     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD000498.pub2     Document Type: Review

References (18)

1. Luciano 1997 {published data only} Luciano R, Velardi F, Romagnoli C, Papacci P, De Stefano V, Tortorolo G. Failure of fibrinolytic endoventricular treatment to prevent neonatal post-haemorrhagic hydrocephalus. Child's Nervous System 1997;13:73-6.
2. Yapicioglu 2003 {published data only} Yapicioglu H, Narli N, Satar M, Soyupak S, Altunbasak S. Intraventricular streptokinase for the treatment of posthaemorrhagic hydrocephalus of preterm. Journal of Clinical Neuroscience 2003;10:297-9. [MEDLINE: 12763331].
3. Hansen a 1997 Hansen A, Whitelaw A, Lapp C, Brugnara C. Cerebrospinal fluid plasminogen activator inhibitor-1: a prognostic factor in posthaemorrhagic hydrocephalus. Acta Paediatrica 1997;86:995-8.
4. Hansen b 1997 Hansen AR, Volpe JJ, Goumnerova LC, Madsen JR. Intraventricular urokinase for the treatment of posthemorrhagic hydrocephalus. Pediatric Neurology 1997;17:213-7.
5. Hill 1984 Hill A, Shackleford GD, Volpe JJ. A potential mechanism of pathogenesis for early posthemorrhagic hydrocephalus in the premature newborn. Pediatrics 1984;73:19-21.
6. Hudgins 1994 Hudgins RJ, Boydston WR, Hudgins PA, Adler SR. Treatment of intraventricular hemorrhage in the premature infant with urokinase. A preliminary study. Pediatric Neurosurgery 1994;20:190-7.
7. Hudgins 1997 Hudgins RJ, Boydston WR, Hudgins PA, Morris R, Adler SM, Gilreath CL. Intrathecal urokinase as a treatment for intraventricular hemorrhage in the preterm infant. Pediatric Neurosurgery 1997;26: 281-7.
8. Levene 1981 Levene MI. Measurement of the growth of the lateral ventricle in preterm infants with real time ultrasound. Archives of Disease in Childhood 1981;56:900-4.
9. Nowak 1999 Nowak S, Rudeck M, Polis L. Intraventricular administration of human recombinant plasminogen activator for posthemorrhagic hydrocephalus of the newborn. Acta Paediatrica 1999;88:995-8.
10. PHVD Trial 1998 International PHVD Drug Trial Group. International randomised controlled trial of acetazolamide and furosemide in posthaemorrhagic ventricular dilatation in infancy. Lancet 1998;352:433-40.
11. Punt 1995 Punt J. Neurosurgical management of hydrocephalus. In: LeveneMI, LilfordRJ editor(s). Fetal and Neonatal Neurology and Neurosurgery. Edinburgh: Churchill Livingstone, 1995:661-6.
12. Shinnar 1985 Shinnar S, Gammon K, Bergman EW, Epstein M, Freedom JM. Management of hydrocephalus in infancy: use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. Journal of Pediatrics 1985;107:31-6.
13. Whitelaw 1992 Whitelaw A, Rivers R, Creighton L, Gaffney P. Lowdose intraventricular fibrinolytic therapy to prevent posthaemorrhagic hydrocephalus. Archives of Disease in Childhood 1992;67:F12-4.
14. Whitelaw 1995 Whitelaw A, Mowinckel M-C, Abildgaard U. Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis?. Acta Paediatrica 1995;84:933-6.
15. Whitelaw 1996 Whitelaw A, Saliba E, Fellman V, Mowinckel M-C, Acolet D, Marlow N. Phase 1 study of intraventricular recombinant tissue plasminogen activator for treatment of posthaemorrhagic hydrocephalus. Archives of Disease in Childhood 1996;74:F20-6.
16. Whitelaw 1999 Whitelaw A, Christie S, Pople I. Transforming Growth Factor Beta-1: A possible signal molecule for posthemorrhagic hydrocephalus. Pediatric Research 1999;46:576-80.
17. Whitelaw 2000 A Whitelaw. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 2000, Issue 1.Art. No.: CD000498. DOI: 10.1002/14651858.CD000498.pub2.
18. Whitelaw 2001 A Whitelaw. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 2001, Issue 1.Art. No.: CD000498. DOI: 10.1002/14651858.CD000498.pub2.[MEDLINE: 11279695].